This is a Multiple Ascending Dose Study to Evaluate the safety and tolerability of a drug called PRX012 in Subjects with Alzheimer’s Disease when compared to a placebo. Joining our clinical trial is a valuable opportunity to contribute to the advancement of medical research while receiving compensation for your participation. Additionally, we may offer reimbursements for clinical trial-related travel expenses and do not require health insurance. Don’t miss out on the chance to make a meaningful impact on the future of healthcare.

To be eligible for this study, a potential participant must:

  • Be between the ages of 55 and 85
  • Have a confirmed or suspected diagnosis of mild Alzheimer’s disease or mild cognitive impairment due to Alzheimer’s disease
  • Have noticed gradual and progressive change in memory function for at least 6 months
  • Be willing and able to complete brain imaging (MRI and PET scans)